Story · Medicine & Biotech · Fitness

Quadruple Agonist Reduced Weight Without Major Muscle Loss in Mid-Stage Trial

1 outlet · first reported by MedPage Today on

(MedPage Today) -- NATIONAL HARBOR, Md. -- An investigational oral quadruple receptor agonist led to substantial weight loss with preservation of lean mass, a randomized phase II trial presented here showed. By week 13, the two highest tested... (MedPage Today)

Coverage, in order

  1. MedPage Today indie study randomized trial
    Quadruple Agonist Reduced Weight Without Major Muscle Loss in Mid-Stage Trial

    (MedPage Today) -- NATIONAL HARBOR, Md. -- An investigational oral quadruple receptor agonist led to substantial weight loss with preservation of lean mass, a randomized phase II trial presented here showed. By week 13, the two highest tested...

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.